Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Insmed reported $30.52M in Trade Debtors for its fiscal quarter ending in March of 2023.

Trade Debtors Change
Alimera Sciences ALIM:US USD 18.43M 1.18M
BioMarin Pharmaceutical BMRN:US USD 597.91M 136.6M
Cytokinetics CYTK:US USD 1.01M 859K
Dynavax Technologies DVAX:US USD 104.87M 42.65M
Gilead Sciences GILD:US USD 4.16B 615M
Heron Therapeutics HRTX:US USD 51.45M 601K
Insmed INSM:US USD 30.52M 810K
Mirati Therapeutics MRTX:US USD 8.59M 4.85M
Novartis NVS:US USD 9.18B 849M
Regeneron Pharmaceuticals REGN:US USD 5.12B 210.1M
Sarepta Therapeutics SRPT:US USD 288.08M 28.38M
Seattle Genetics SGEN:US USD 495.78M 6.14M
Ultragenyx Pharmaceutical RARE:US USD 42.99M 2.55M
Vertex Pharmaceuticals VRTX:US USD 1.55B 105.6M